Showing 841-850 of 1110 results for "".
- Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Dayhttps://modernod.com/news/johnson-johnson-vision-launches-worldwide-campaign-to-spotlightsight-in-honor-of-world-sight-day/2479805/Sight is the most prized of all human senses. Yet, there are many people who do not fully experience the wonder of this gift. Nearly 285 million people around the world face impaired vision, and 80 percent of those cases are preventable with early diagnosis and treatment. That’s why Johnson
- Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at ESCRShttps://modernod.com/news/johnson-johnson-vision-showcases-latest-clinical-data-and-eye-care-solutions-at-escrs/2479857/Johnson & Johnson Vision highlighted key clinical data and latest solutions at the ESCRS meeting in Vienna. The company will offer a series of educational sessions for the ophthalmology community about the latest advancements in surgical vision, including diagnostic tools, available treatment
- Johnson & Johnson Vision Presents New Data on Silicone Hydrogel Contact Lens Muco-Adhesive Propertieshttps://modernod.com/news/johnson-johnson-vision-presents-new-data-on-silicone-hydrogel-contact-lens-muco-adhesive-properties/2480192/Johnson & Johnson Vision presented new data at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Honolulu, Hawaii. The data measured how the extent of crosslinking affects muco-adhesion in a laboratory study with corneal epithel
- Johnson & Johnson Vision Highlights New Data at 2018 ARVO Annual Meetinghttps://modernod.com/news/johnson-johnson-vision-highlights-new-data-at-2018-arvo-annual-meeting/2480201/Johnson & Johnson Vision announced that a suite of new research from its eye health portfolio will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii from April 29 to M
- Johnson & Johnson Vision Introduces Contact Lens with Transitions Light Intelligent Technologyhttps://modernod.com/news/johnson-johnson-vision-announces-contact-lens-innovation-with-acuvue-oasys-with-transitions-light-intelligent-technology/2480264/Johnson & Johnson Vision has introduced the Acuvue Oasys with Transitions Light Intelligent Technology, a first-of-its-kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye, acco
- Eye Foundation of America Hosts Fundraising Galahttps://modernod.com/news/eye-foundation-of-america-hosts-fundraising-gala/2482734/On April 12, the Eye Foundation of America is hosting a Spring fundraiser gala in New Rochelle, New York. Under the leadership of Surendra Sharma, MD and Rachana Shukla, MD, the group hopes to raise funds to help support a new state-of-the-art green hospital in India, as well
- Oculis and Euretina Announce Winner of Inaugural Ramin Tadayoni Awardhttps://modernod.com/news/oculis-and-euretina-announce-winner-of-inaugural-ramin-tadayoni-award/2482449/Oculis, in partnership with Euretina, has announced the first recipient of the Ramin Tadayoni Award: Dr. Andrea Govetto, MD, PhD. The award honors the memory of Oculis' late Chief Scientific Officer and renowned retina specialist, Professor Ramin Tadayoni, MD, who passed away unexpectedly ear
- Inaugural Eyecelerator Innovation Award Presented to Regeneron Executiveshttps://modernod.com/news/inaugural-eyecelerator-innovation-award-presented-to-regeneron-executives/2482404/Leonard Schleifer, MD, PhD, and George Yancopoulos, MD, PhD, of Regeneron Pharmaceuticals were awarded the first Eyecelerator Innovation Award. "This year's Eyecelerator Innovation Award honors the remarkable physician-led, science-dr
- NEI Director Highlights Metabolomics as an Approach to Understanding Glaucomahttps://modernod.com/news/nei-director-highlights-metabolomics-as-an-approach-to-understanding-glaucoma/2481982/The National Eye Institute (NEI) announced that NEI Director Michael F. Chiang, MD, featured recent research by NEI grantee Louis Pasquale, MD, in a National Institute of Health Director’s Blog post. Dr. Pasquale in collaboration with Jae Hee Kang, ScD, and Oana Zeleznik, PhD, explored 369
- EyePoint Pharmaceuticals Forms Executive Scientific Advisory Boardhttps://modernod.com/news/eyepoint-pharmaceuticals-forms-executive-scientific-advisory-board/2479426/EyePoint Pharmaceuticals announced the formation of its Executive Scientific Advisory Board (SAB), chaired by Carl Regillo MD, FACS, Chief of the Retina Service at Wills Eye Hospital. Other members of the SAB include Sophie J. Bakri, MD, Mayo Clinic; Caroline R. B